You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|
|---|---|
| Published in |
Blood, July 2019
|
| DOI | 10.1182/blood.2019001160 |
| Pubmed ID | |
| Authors |
Constantine S Tam, Judith Trotman, Stephen Opat, Jan A Burger, Gavin Cull, David Gottlieb, Rosemary Harrup, Patrick B Johnston, Paula Marlton, Javier Munoz, John F Seymour, David Simpson, Alessandra Tedeschi, Rebecca Elstrom, Yiling Yu, Zhiyu Tang, Lynn Han, Jane Huang, William Novotny, Lai Wang, Andrew W Roberts |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 17% |
| France | 3 | 13% |
| United Kingdom | 2 | 9% |
| Japan | 2 | 9% |
| United States | 1 | 4% |
| Colombia | 1 | 4% |
| Russia | 1 | 4% |
| Australia | 1 | 4% |
| Unknown | 8 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 61% |
| Practitioners (doctors, other healthcare professionals) | 4 | 17% |
| Scientists | 3 | 13% |
| Science communicators (journalists, bloggers, editors) | 2 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 175 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 14% |
| Other | 13 | 7% |
| Student > Ph. D. Student | 12 | 7% |
| Student > Master | 10 | 6% |
| Student > Bachelor | 10 | 6% |
| Other | 26 | 15% |
| Unknown | 79 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 18% |
| Biochemistry, Genetics and Molecular Biology | 17 | 10% |
| Chemistry | 10 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 16 | 9% |
| Unknown | 88 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#876,276
of 25,385,509 outputs
Outputs from Blood
#598
of 33,256 outputs
Outputs of similar age
#18,651
of 358,814 outputs
Outputs of similar age from Blood
#14
of 206 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,256 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 206 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.